Clinical research disturbed by high VAT and red tape

APA - Austria Presse Agentur
08-03-2006, 16:35

Warsaw (Puls Biznesu) – The PLN 1 billion (EUR 258m) clinical tests market struggles due to too many barriers. Poland may lose the market to its neighbors.

Warsaw (Puls Biznesu) – The PLN 1 billion (EUR 258m) clinical tests market struggles due to too many barriers. Poland may lose the market to its neighbors.

Poland stops being an attractive site to run clinical research on new medicines. The number of new projects has not exceed 400 for several years now. Many projects go to the other countries in the region, including the Czech Republic and Hungary.

“They have 15 percent growth of new tests. The Hungarians lunch 300 projects each year, the Czech 250. In Poland the level has not changed for several years now”, Wojciech Maselbas, the CEO of the Accociation for Good Practices in Clinical Research in Poland said.

Paradoxically, the EU accession made the situation even more difficult.

“Entities registering clinical research should announce their stance within 60 days. If they fail to refuse the permission for such tests in Poland, it is assumed that they have agreed for that. Most often, in the eleventh hour they ask for more data. In effect, it takes 85 days to start a project while it was 42 days before Poland’s EU accession”, Wojciech Maselbas said.

Another problem is high VAT.

“The Polish tax authorities demand that the Polish firms rendering services to a foreign company add 22 VAT. According to EU regulations, the expert service should be taxed in the country of the company ordering it, not in Poland. A US company investing EUR 1m in Poland pays UD 220,000 more than if it did it in Belgium”, Mariusz Ignatowicz, a partner in PricewaterhouseCoopers said.

About 80 companies order clinical tests. In Poland, it takes 75.45 days to register a product clinically tested. In Slovakia it is 65.45 days, in Hungary 65.54 days, in the Czech Republic 52.72 days and in Sovenia 28.64 days.

(PLN 1 = EUR 0.258)

 

© ℗
Rozpowszechnianie niniejszego artykułu możliwe jest tylko i wyłącznie zgodnie z postanowieniami „Regulaminu korzystania z artykułów prasowych” i po wcześniejszym uiszczeniu należności, zgodnie z cennikiem.

Podpis: APA - Austria Presse Agentur

Polecane

Inspiracje Pulsu Biznesu

Tematy

Puls Biznesu

Inne / Clinical research disturbed by high VAT and red tape